ABAnnie Brink

Annie Brink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Annie Brink has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Axial spondyloarthritis patients with comorbid fibromyalgia feel worse, work less and more often try multiple biological therapies: results from a population-based, cross-sectional study investigating the discriminative capacity of pressure algometry

    by Annie Brink, Elisabeth Mogard, Elisabet Lindqvist, Jonas Sagard, Carmen Roseman, Mats Geijer, Jack Kvistgaard Olsen, Johan K. Wallman, Tor Olofsson

    To estimate prevalence and associated factors of comorbid fibromyalgia in axial spondyloarthritis (axSpA), and to explore discriminative capacity (for discerning fibromyalgia) of algometry-assessed pain sensitivity measures. AxSpA patients from the population-based SPARTAKUS cohort evaluated for fibromyalgia (1990 ACR criteria) were included ( n = 243; r-axSpA/nr-axSpA = 165/78). Factors associated with fibromyalgia were cross-sectionally analyzed by logistic/linear regression, and discriminative potential of algometry-assessed measures estimated by ROC-curve analysis. A fibromyalgia prevalence of 9% was demonstrated, with a higher frequency in female than male patients (17%/2%;adjusted p < 0.001) and more than a doubling in frequency per 5-unit BMI increase (adjusted p < 0.002). Fibromyalgia was associated with several disease/work outcomes, including higher disease activity, lower quality-of-life, and less employment although without association to swollen joints/CRP. Additionally, patients with (versus without) fibromyalgia had higher bDMARD exposure (19%/5% had tried ≥ 3 bDMARDs; adjusted p = 0.009), and were more often on opioids (62%/16%;adjusted p < 0.001). Algometry-assessed measures displayed a sensitivity/specificity of 79%/70% (pain threshold) and 71%/83% (pain tolerance) for fibromyalgia differentiation (positive/negative predictive values 16%/99% and 23%/98%, respectively). Fibromyalgia is a frequent comorbidity in axSpA, more common in female patients/patients with higher BMI, and associated with worse levels of patient-reported disease/work outcomes. Our findings highlight the challenge of assessing axSpA disease activity when fibromyalgia is present and suggest a role for algometry as a complementary, evaluator-independent assessment tool, potentially useful for fibromyalgia rule-out but less so for rule-in. The results further suggest that fibromyalgia may be associated with DMARD overtreatment, reflecting a need for earlier and more precise targeting.


  • Open Access

    Sex‐Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population‐Based Historical Cohort Study of Middle‐Aged and Older Individuals

    by Annie Brink, Johan Elf, Peter J. Svensson, Gunnar Engström, Olle Melander, Bengt Zöller

    Background: Whether sex‐specific differences exist for risk factors for pulmonary embolism (PE) and deep venous thrombosis (DVT), with the exception of pregnancy and estrogen therapy, has been sparsely studied. We aimed to study whether sex‐specific differences of risk factors exist for noncancer‐related DVT and PE in middle‐aged and older individuals without cardiovascular history or previous diagnosis in a population‐based historical (retrospective) cohort. Methods and Results: Potential venous thromboembolism (VTE) risk factors were registered at baseline in 15 807 women and 9996 men aged 44 to 74 years, who participated in the Malmö Diet and Cancer study (1991–1996). We excluded subjects with a previous history of VTE, cancer, a diagnosis of cardiovascular disease, or a diagnosis of cancer‐associated VTE during follow‐up. Patients were followed up from baseline until the first event of PE or DVT, death, or December 31, 2018. During the follow‐up period, 365 (2.3%) women and 168 (1.7%) men were affected by first DVT, and 309 (2.0%) women and 154 (1.5%) men were affected by first PE. In the multivariable Cox regression models, the anthropometric obesity markers of weight, body mass index, waist and hip circumference, fat percentage, and muscle weight were in a dose‐dependent way associated with DVT and PE among women but not men. In an analysis that included patients with cardiovascular disease and cancer‐related VTE, the results were similar for women. For men, several obesity measures became significantly associated with PE or DVT but were weaker than in women, especially for DVT. Conclusions: Anthropometric obesity measures are more important risk factors for both DVT and PE among women than men, especially for individuals without cardiovascular history or previous diagnosis or cancer‐related VTE.